Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.
CardiaCare, Corveus Medical, and Cardiospire, three cardiovascular start-ups that have been part of a MedTech Innovator cohort, each offers a new approach to managing heart disease, from clinical monitoring to intervention, aimed at reducing invasiveness and increasing accessibility of treatment.
Vensana’s Greg Banker discusses his firm’s decision to invest $20 million in biomaterials play Artelon. Excerpted from our recent feature article, Vensana's $20 Million Bet on Artelon's Potential in Soft-Tissue Repair.